BANKING & FINANCE - May 1, 1995
- Share via
<i> Times Staff and Wire Reports</i>
Merck & Co. said it won clearance from the U.S. Food and Drug Administration to sell its Pepcid ulcer drug to treat heartburn and acid indigestion without a prescription, starting in June.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
